bioRxivMicrobiology
Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns
P. D. Yadav, G. Sapkal, R. R. Sahay, V. Potdar, G. Deshpande, D. Y. Patil, D. A. Nyayanit, A. M. Shete, J. Shastri, P. Awate, B. Malhotra, P. Abraham
Abstract
The recent emergence of highly mutated SARS-CoV-2 Omicron variant has debilitating effect on public health system of the affected countries worldwide. Currently India is facing third wave of COVID-19 pandemic and going through a severe crisis. Within short span of time, the variant has shown high transmissibility and capability of evading the immune response generated against natural infection and vaccination. The immune escape potential of Omicron is a serious concern and further needs to be explored. In the present study, we have assessed the IgG and neutralizing antibody (NAb) response in breakthrough individuals vaccinated with two doses ChAdOx1 nCoV-19 vaccine (n=25), breakthrough individuals vaccinated with two doses of BNT162b2 mRNA vaccine (n=8) and unvaccinated individuals (n=6). All these individuals were infected with Omicron variant. The IgG antibody activity in the sera of the ChAdOx1 nCoV-19 and BNT162b2 mRNA breakthrough individuals was comparable with S1-RBD, while it was lesser in BNT162b2 mRNA breakthrough individuals with N protein and inactivated whole antigen IgG ELISA. BNT162b2 mRNA breakthrough individuals showed moderate reduction in NAb GMTs compared to ChAdOx1 nCoV-19 against Alpha, Beta and Delta. However, 3-fold higher reduction was observed with omicron variant in BNT162b2 mRNA than ChAdOx1 nCoV-19. Apparently, Alpha variant was modestly resistant to the sera of unvaccinated individuals than Beta, Delta and Omicron. Our study demonstrated substantial immune response in the individuals infected with Omicron. The neutralizing antibodies could effectively neutralize the Omicron and other VOCs including the most prevalent Delta variant.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Vaccine-breakthrough infection by the SARS-CoV-2 Omicron variant elicits broadly cross-reactive immune responses
R. Zhou, K. K.-W. To, … Z. Chen·bioRxiv·Dec 27, 2021
- Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization
D. Planas, N. Saunders, … O. Schwartz·bioRxiv·Dec 14, 2021
- Poor neutralizing antibody responses against SARS-CoV-2 Omicron BQ.1.1 and XBB in Norway in October 2022
E. L. Vikse, E. Fossum, … K. Bragstad·bioRxiv·Jan 5, 2023
- mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant
V.-V. Edara, K. E. Manning, … M. S. Suthar·bioRxiv·Dec 20, 2021
- Reduced infectivity but increased immune escape of the new SARS-CoV-2 variant of concern Omicron
J. Hu, P. Peng, … A.-l. Huang·bioRxiv·Dec 24, 2021
- The Omicron variant is highly resistant against antibody-mediated neutralization - implications for control of the COVID-19 pandemic
M. Hoffmann, N. Krüger, … S. Pöhlmann·bioRxiv·Dec 12, 2021